Latest Oasmia Pharmaceutical AB Stories

2015-04-20 12:33:26

UPPSALA, Sweden, April 20, 2015 /PRNewswire/ -- Oasmia Pharmaceutical AB ("Oasmia") announced today that its lead cancer product Paclical received market authorization

2010-07-15 01:59:00

UPPSALA, Sweden, July 15, 2010 /PRNewswire-FirstCall/ -- - A Number of Promising New Product Candidates for Cancer Treatment, Within Both Human and Veterinary Oncology ABOUT OASMIA Oasmia is developing a new generation of drugs with emphasis on human and veterinary oncology.

2009-07-10 08:00:00

ABBOTT PARK, Ill. and UPPSALA, Sweden, July 10 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) and Oasmia Pharmaceutical have announced a multi-year agreement to market one of the first cancer medications for dogs.

2009-04-14 05:20:00

UPPSALA, Sweden, April 14 /PRNewswire-FirstCall/ -- Oasmia Pharmaceutical, Uppsala, Sweden, has been granted Orphan Drug designation by the USA FDA of Paclical(R) for the treatment of ovarian cancer.

Word of the Day
  • A young chicken: also used as a pet name for children.
The word 'chickabiddy' may come from 'chick' plus 'biddy', a name used in calling a hen or chicken.